Vanda Pharmaceuticals
VNDA
#7861
Rank
HK$2.47 B
Marketcap
HK$41.96
Share price
3.65%
Change (1 day)
11.43%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Net assets

Net assets on the balance sheet as of September 2025 : HK$3.62 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has HK$3.62 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$4.18 B-1.76%
2023-12-31$HK$4.25 B3.32%
2022-12-31$HK$4.11 B4.62%
2021-12-31$HK$3.93 B12.05%
2020-12-31$HK$3.51 B9.79%
2019-12-31$HK$3.20 B48.39%
2018-12-31$HK$2.15 B110.11%
2017-12-31$HK$1.02 B0.8%
2016-12-31$HK$1.01 B-1.23%
2015-12-31$HK$1.03 B-17.34%
2014-12-31$HK$1.24 B264.57%
2013-12-31$HK$0.34 B345.65%
2012-12-31$HK$76.77 M-70.47%
2011-12-31$HK$0.25 B-11.46%
2010-12-31$HK$0.29 B64.43%
2009-12-31$HK$0.17 B-49.78%
2008-12-31$HK$0.35 B-45.53%
2007-12-31$HK$0.65 B213.71%
2006-12-31$HK$0.20 B-12.47%
2005-12-31$HK$0.23 B91.89%
2004-12-31$HK$0.12 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
HK$348.37 B 9,503.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$185.66 B 5,018.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$617.13 B 16,912.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 3,891.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.71 B 19,877.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
HK$21.7 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$404.07 B 11,038.87%๐Ÿ‡บ๐Ÿ‡ธ USA